Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
Yan Zhou et al · BMC · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, Y. Z. E. (2026). Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant. https://doi.org/10.1186/s12985-026-03173-7
MLA
al, Yan Zhou et. "Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant." 2026. https://doi.org/10.1186/s12985-026-03173-7.
Chicago
al, Yan Zhou et. 2026. "Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant.". https://doi.org/10.1186/s12985-026-03173-7.
Harvard
al, Y. Z. E. 2026, Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant, BMC, available at: https://doi.org/10.1186/s12985-026-03173-7 [Accessed 30 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Correction: Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
- Autor / colaboradores
- Yan Zhou et al
- Editorial
- BMC
- Año de publicación
- 2026
- ISSN
- 1743-422X
- ISSN
- 1743-422X
- Idioma
- eng